Baiyunshan Biology

Guangzhou Baiyunshan Biological Products Joint-stock Co., Ltd. (hereinafter referred to as Baiyunshan Biology) was established on April 20, 2006. It is a high-tech core enterprise in the biomedical sector under Guangyao Group and Guangyao Baiyunshan (listed on Hong Kong H-shares and Shanghai A-shares), a Fortune Global 500 state-owned listed company. It is a biological products joint-stock company integrating research and development, production, and sales. The company has a registered capital of 84 million RMB, with an existing plant area of 10,000 square meters. The new plant area, planned, designed, and constructed according to international standards, is nearly 20,000 square meters, and is equipped with production workshops that fully comply with GMP standards. The production process is under comprehensive GMP-standard management.

The production center of Baiyunshan Biology is located in Wanbao Industrial Base, Panyu District, Guangzhou, with its registered address at No. 406 Lianyun Road, Guangzhou Economic and Technological Development Zone. The plant environment is clean, and internal management is standardized. The company focuses on the research, development, and production of new vaccines. It is a nationally recognized high-tech enterprise and a key human vaccine R&D and production enterprise supported by Guangzhou, based in Guangzhou and serving the global market.

Baiyunshan Biology has nearly 200 employees, with over 70% being professional and technical personnel with college degrees or above. The company continuously introduces industry experts to build a vaccine technology talent team, and places great emphasis on corporate culture development and human resource training and development, providing employees with a broad platform to showcase themselves and realize personal value.